| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| MIR146B |
|
microRNA 146b
|
|
|
0.496 |
0.769 |
| H3P9 |
|
H3 histone pseudogene 9
|
|
|
0.505 |
0.731 |
| H3P40 |
|
H3 histone pseudogene 40
|
|
|
0.506 |
0.846 |
| LOC102723407 |
|
immunoglobulin heavy variable 4-38-2-like
|
|
|
0.514 |
0.769 |
| LOC102724971 |
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
|
0.527 |
0.769 |
| TMX2-CTNND1 |
|
TMX2-CTNND1 readthrough (NMD candidate)
|
|
|
0.538 |
0.769 |
| MIR26B |
|
microRNA 26b
|
|
|
0.529 |
0.808 |
| KIR2DS1 |
Q14954
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.537 |
0.769 |
| IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
| IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
| LOH19CR1 |
|
loss of heterozygosity, 19, chromosomal region 1
|
|
|
0.569 |
0.808 |
| SSX2 |
Q16385
|
SSX family member 2
|
Nucleic acid binding
|
|
0.581 |
0.615 |
| MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
| MT1JP |
|
metallothionein 1J, pseudogene
|
|
|
0.588 |
0.731 |
| MIR24-1 |
|
microRNA 24-1
|
|
|
0.584 |
0.731 |
| MIR421 |
|
microRNA 421
|
|
|
0.592 |
0.692 |
| SSX2B |
Q16385
|
SSX family member 2B
|
|
|
0.599 |
0.577 |
| FSHMD1A |
|
facioscapulohumeral muscular dystrophy 1A
|
|
|
0.638 |
0.808 |
| KIR3DS1 |
Q14943
|
killer cell immunoglobulin like receptor, three Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.617 |
0.692 |
| MIR155HG |
|
MIR155 host gene
|
|
|
0.617 |
0.615 |
| LOC105379528 |
|
uncharacterized LOC105379528
|
|
|
0.617 |
0.615 |
| LOC390714 |
|
immunoglobulin heavy chain variable region
|
|
|
0.617 |
0.615 |
| TRG |
|
T cell receptor gamma locus
|
|
|
0.631 |
0.538 |
| TRA |
P0DSE1
|
T cell receptor alpha locus
|
|
|
0.628 |
0.577 |